Substantial numbers of both cr and 3'//i T cells are present in human fetal liver, which suggests a role of the fetal liver in T cell development. The diversity of fetal liver T cell receptor (TCK) 3' and ~ chain rearrangements was examined among both CD4+CD8 -and CD4-CDS-3'/c5 T cell clones. In addition, TCR 5 chain transcripts from three fetal livers were sequenced after polymerase chain reaction amplification of TCR $ chains with V~I or Va2 rearrangements. Five of six fetal liver 3'//t T cell clones had a Va2-Da3-Ja3 gene rearrangement with limited junctional diversity; three of these clones had an unusual CD4+CD8 -phenotype. V~2-D63-J63 gene rearrangements were also common among both in-frame and out-of-frame transcripts from three fetal livers, indicating that they are the result of an ordered rearrangement process. TCK 3' chain sequences of the fetal liver 3'/~5 T cell clones revealed V~l-J,2.3, V,2-J,1.2, and V,3-J,l.1 rearrangements with minimal incorporation of template-independent N region nucleotides. TCR 3' chain rearrangements found in these fetal liver T cell clones were different from those that have been observed among early thymic 3"/c5 T cell populations, while similar TCK/i chain rearrangements are found among 3'/~5 T cells from both sites. These data demonstrate that the fetal liver harbors 3'/~5 T cell populations distinct from those found in the fetal thymus, suggesting that the fetal liver is a site of 3'//t T cell development in humans. These unusual T cell populations may serve a specific function in the fetal immune system. 3"/c5 T cells are a distinct subset of mature T cells defined by the expression of rearranged TCR 3" and ~5 genes (1, 2).
3"/c5 T cells are a distinct subset of mature T cells defined by the expression of rearranged TCR 3" and ~5 genes (1, 2) . A number of studies performed in mice have demonstrated a developmental pattern of3'/5 TCK rearrangements as well as localization of 3'/~5 T cells with defined TCR rearrangements to specific organs. For example, 3'//t T cells in mouse intestinal mucosa and mesenteric lymph nodes preferentially use V,7, while 3'/~5 T cells in skin use the Vv3 gene segment (3, 4) . Such epithelial 3'/c5 T cells are thought to have specific functions in the immune surveillance of epithelial tissues, such as the lysis of infected or transformed cells (5) .
In humans, the developmental pattern of 3'/~5 TCR rearrangements is not as well understood as it is in mice. Nevertheless, there is evidence that the occurrence of human 3"/c5 T cell populations is also developmentally regulated. In fetal thymus, the major population of TCK c5 chains is rearranged to the V~2 gene segment, while Val § T cells represent the major population of3'/5 T cells in postnatal thymus and blood of newborns (6) (7) (8) (9) . However, 6 mo after birth V62 + 3'/r T cells become the predominant 3,//t T cell population in blood while V~I § T cells continue to be the major 3'/8 T cell population in the thymus (10, 11) .
Murine fetal liver is not only a site at which T cell precursors develop from immature cells but also an organ in which 3'/li T cells can mature. Nude mice were found to have substantial numbers of intestinal intraepithelial 3,/c5 T cells despite the almost complete absence of ot/B T cells. Furthermore, intraepithelial 3'/~ T cells could be reconstituted in lethally irradiated mice by injection of fetal liver precursors, even in thymectomized animals (12) . Since at least a subset of 3'//i T cells is thymus independent, fetal liver is a likely site of extrathymic 3'/~5 T cell maturation.
The presence of substantial numbers of3"/~ T cells in human fetal liver as well as the unusual CD4 + phenotype of a subpopulation of fetal liver 3'//~ T cells support the hypothesis that fetal liver is also a site of extrathymic 3'//t T cell maturation in humans. Both ot//~ and 3'/c5 T cells have been cultured from human fetal liver and represent '~63 and '~32% of CD3 + T cells, respectively. By surface expression of CD4 and CD8 molecules, three subsets of CD3 + T cells in human fetal liver were identified. Approximately 20% of fetal liver 3'/8 T ceils have a CD4+CD8 -phenotype that is infrequent among 3'/8 T ceils in thymus or blood. In contrast to CD4-CD8-and CD4-CD8 + 3'/8 T cells, CD4+CD8 -3'/8 T cells from fetal liver were found to lack cytotoxic activity (13) (14) (15) . Together, these data suggest that fetal liver y/8 T cells represent a distinct T cell population. In the present paper, TCR 3/and 8 chain rearrangements of CD4+CD8 -and CD4-CD8-fetal liver "//8 T cell clones were examined. The data indicate that fetal liver 3'/8 T cells represent T cell populations distinct from thymic y/8 T cells.
Materials and Methods
Cell Preparations. T Cell Cloning. Fetal liver T cell clones L3, L6, L7, L25, and L38 were isolated from FL 5/27 by direct single cell cloning on day 0, while fetal liver clones L2G9, L4B2, L7F11, L4G1, and L7F5 were generated from FL 2/9 after enrichment of TCR ~ § T cells by magnetic bead separation. For cloning, T cells were grown in RPMI, 10% human serum (Biocell), 10-20% conditioned media (delectinized supematant from PHA-stimulated blood mononuclear cells) at one cell/well in U-bottomed microtiter plates using 2 x 104 irradiated mononuclear cells and 104 irradiated JY cells (an EBV-transformed B cell line) per well. After 2 wk, growth-positive wells were expanded with fresh feeder cells and IL-2. For bead selection, fetal liver cells were incubated with TCK-6I mAb (1:500 dilution of ascites) in RPMI, 2% FCS for 30 min at 4~ and washed in RPMI, 3% BSA. Antibody-coated cells were incubated with magnetic goat anti-mouse beads (Dynal) for 15 min at 37~ and TCK-~l-positive cells recovered by magnetic bead separation and repeated washing of beads. Cells were cultured for 1-3 wk and cloned as described above.
RNA Preparation and cDNA Synthesis. RNA was prepared from 0.5-10 x 106 cells using the RNAzol B method (Cinna/Biotecx). Cells were washed twice with PBS and then homogenized in 1 ml of KNAzol B. 100/zl of chloroform was added and the sample centrifuged at 4~ The upper, clear phase was transferred to a clean tube arid RNA was precipitated by addition of an equal volume ofisopropanol. When small numbers of cells were available for RNA preparation, 10 #g of tRNA was added as a carrier in the isopropanol precipitation step. After a 15-min incubation on ice, samples were centrifuged at 4~ The RNA pellet was washed with 1 ml of cold 70% ethanol and air dried. RNA was resuspended in 10 #1 of autoclaved H20 and stored at -80~ cDNAs were synthesized from 1-2 #g of KNA using oligo(dT) as a primer and AMVreverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD) (20) . cDNAs were diluted to 200 #1 with autoclaved H20 and stored at -80~ 5-10 #I of diluted cDNA was used for each PCR amplification. Val to Va5 primers have a SalI restriction site for cloning of PCR products into M13 vectors, while one of the Ca primers has an EcoRI restriction site to facilitate cloning. For amplification of TCR 3/chains, Vv primers were used in combination with either Cv primer (Cv-BamHI is located closer to the 5' end of Cs). To prevent contamination of samples, reagents used for cDNA synthesis and PCK amplification were tested for possible contamination. Negative controls (all primer combinations, no cDNA) were included in experiments in order to detect accidental contamination.
PCR Amplification and
PCK products were analyzed on 1% agarose gels stained with ethidium bromide. For Southern blot analysis, gels were denatured, neutralized, and PCR products transferred to nitrocellulose paper (Schleicher & Schuell, Inc., Keene, NH). Amplified DNA was hybridized to an internal Ca olignnucleotide probe endlabeled using 3-[32p]ATP and T4 polynucleotide kinase (Bethesda Research Laboratories). Hybridizations were performed for 18 h at 37~ in a buffer containing 6 x SSC, 0.05 % pyrophosphate, 5 x Denhardt's, 0.5% SDS, 0.1 mg/ml of denatured salmon sperm DNA. After hybridization at 37~ for 18 h, filters were washed at a final stringency of6x SSC, 70~ (C+ probe) or 6x SSC, 50~ (Ja probes) and processed for autoradiography (20) .
DNA Sequence Analysis. V+-Ca PCK products, M13 mp19
plasmid DNA, and pUC-18 DNA were digested with EcoKI and SalI restriction endonucleases to generate compatible ends for
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T Cell Receptor Rearrangements of Fetal Liver y/6 T Cells cloning. The digested plasmid was treated with bacterial alkaline phosphatase (Bethesda Research Laboratories). Digested PCR products were gel purified, ligated to plasmid DNA, and used to transform JM101-competent cells. PCR products from fetal liver T cell clones were cloned into pUC-18 while TCR/~ chain amplification products from fetal liver were cloned into M13 rap19. DNA was sequenced by the dideoxy method (21) using the M13 universal primer and c~-3sS-ATP as radiolabeled nucleotide. For sequence analysis of TCR 3' chains, PCR products were cloned into the pCRII vector (TA cloning system; Invitrogen, San Diego, CA) doublestranded plasmid DNA was sequenced by the dideoxy method using C~-BamHI as a primer.
Results

Analysis of TCR 8 Chain Rearrangements in Human Fetal
Liver. The TCR/~ chain repertoire in human fetal liver was examined by PCR amplification of cDNAs synthesized from fetal liver IkNA (using primers specific for V01 to V05 gene segments in combination with a Ca primer). RNA was extracted from one fetal liver tissue sample (FL 2/9) and from two samples (FL 2/27 and FL 1/9) that had been enriched for T cells by PHA stimulation. Amplification of V01 to V05 gene segments from fetal liver cDNA resulted in bands for V01 and V02 reactions on ethidium bromide-stained agarose gels that hybridized to an internal Co oligonucleotide probe. Among all three fetal liver samples as well as in a PBL sample from an adult volunteer, V~2 amplifications gave the strongest signal indicating that the majority of TCtL /~ chains in fetal liver and adult blood (10, 11, 22) are rearranged to V~2. Trace amounts of V03, V04, and V05 were amplified from one fetal liver sample (FL 2/9) (Fig. 1 ).
To determine J0 gene usage of fetal liver TCR ~ chains, V0 gene segments were amplified from cDNA using V01 to V05 primers in combination with a Co primer followed by Southern blot hybridization with probes for Jal, J~2, and Js3 gene segments. Hybridization of V02-C0 and V01-C0 reac- Figure 1 . Southern blot analysis of the TCR ~ chain repertoire in human fetal liver. TCR ~ chains were amplified from fetal liver cDNA using primers specific for V/~I to V~5 gene segments in combination with a C~ primer. Southern blots were hybridized to an internal 32p-labeled C~ oligonucleotide probe. (A) Fetal liver 1/9; (B) fetal liver 2/9; (C) fetal liver 2/27; (D) blood cDNA from an adult subject; (E) negative control (no cDNA).
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tions to a J~3 probe gave strong signals for all fetal liver samples while weaker signals were detected using probes for Jbl and J02 (Fig. 2) . In contrast, products from a V02-C0 amplification using cDNA from adult blood T cells gave a strong hybridization with a J01 probe; only trace amounts of V02-J03 rearrangements were detected in adult blood. This was expected as the majority of TCR/i chains in adult blood are rearranged to the J01 gene segment (10) . These data indicate that V02-Js3 is the predominant TCR ~ chain rearrangement in human fetal liver and that V02 as well as V01 are preferentially rearranged to the J~3 gene segment.
Sequence Analysis of Vd and V~2
Rearrangements from Human Fetal Liver Samples. In both fetal livers (FL 2/27 and FL 2/9), the majority of V~2 gene segments were rearranged to J03 (22/24 sequences, 91.6%). Also, 21 of 22 TCR/~ chains with a V~2-J~3 rearrangement carried the D~3 but not the D01 gene segment (Fig. 3 ). Only few, if any, N region nudeotides were present at the VDJjunctions. An exception to this rule was sequence 9 (fetal liver 2/27), which contained an unusually long N region between Da3 and Jr3 consisting of a repeated TGAAACC(T) sequence. All four V01 gene segments sequenced were also rearranged to D63 and J03 (Fig. 3) . V0-J0 rearrangements in fetal liver are therefore almost exclusively rearranged to D03 and J03 with limited junctional diversity. In contrast, TCR ~ chains from mature 3'//~ T cells are most commonly rearranged to J01, use D01, D02, and D03 (frequently in tandem), and have extensive N region diversity (22) (23) (24) (25) .
The predominant V02-J~3 gene rearrangement observed in these two fetal livers could result from a regulated rearrangement process or from positive selection of 3'//~ T cells bearing specific TCR chains. Since 7 of 22 V02-J03 sequences were in frame, the predominance of V02-D03-J03 rearrangements is most likely due to the presence of a regulated TCR ~ chain rearrangement process in human fetal fiver. The relative proportion of in-frame and out-of-frame rearrangements is consistent with the theoretical prediction that one-third of rearrangements should lead to an in-frame sequence.
Cloning of cr/fl and 7/8 T Cells from Human Fetal Liver.
Since fetal liver 3'//~ T cells with an unusual CD4+CD8 -phenotype have been described (13, 14) , it was of interest to determine TCR ~ chain rearrangements in fetal liver T cell clones with defined phenotypes. Fetal liver T cells were cloned by direct single cell cloning from fetal liver 5/27 (clones L3, L6, L7, L25, L38) using IL-2 as well as irradiated mononuclear cells and an irradiated EBV-transformed B cell line (JY) as a feeder layer. T cell clones were also generated from fetal liver 2/9 (clones L2G9, L4B2, L7F11, L4G1, L7F5) by magnetic bead selection of T cells expressing the TCK c5 chain followed by in vitro expansion and single cell doning. Of the 10 clones generated (Fig. 4) , six had surface expression of the TCR ~ chain (mAb TCR-~I). Three of these 3,/~5 T cell clones (L3, L7, and L2G9) had moderate levels of CD4 expression, while clones L4B2, L25, and L7F11 were CD4-CDS-. Some of the 3'h5 T cell dones also had weak staining with the WT31 mAb; however, it is unlikely that these clones contained a second ot/fl T cell population since >99% of cells from each done were strongly stained by the Figure 2 . J~ gene usage of TCR chains in human fetal liver. Fetal liver cDNA was amplified using primers for Vel to V~5 in combination with a C~ primer. Amplified products were separated on agarose gels and Southern blots hybridized to J61, J62, and J~3 probes. Blood cDNA from mature T cells was used as a positive control, and negative controls included amplification of V#I to V~5 with a Ce primer in the absence of cDNA. This analysis demonstrated that in fetal liver both V#I to V~2 gene segments are predominantly rearranged to the J~3 gene segment, while the majority of V~I to V62 gene segments among mature blood T cells are rearranged to J~l. TCR-81 mAb. Four clones (L6, L38, L4G1, L7FS) expressed the TCR o~/3 as indicated by surface staining with the WT31 mAb. Two of the oL/3 T cell clones were CD4 + (L6, L38), while two other clones were CD4+CD8 + (L4G1, L7F5). Thus, two unusual phenotypes were observed among these clones: three of six clones that expressed the TCR 8 chain had a CD4+CD8 -phenotype, while two of four clones that expressed the c~/3 TCR were CD4 § CD8 § .
Three of the T cell clones positive for the TCR-81 mAb were further characterized for surface expression of TCR V61-J~l gene segments (mAb 8TCS1), the TCR Vs2 gene segment (mAb Ti3,A), and the TCR V~2 gene segment (mAb BB3). Three of four clones were found to express the TCR V62 gene segment, while only one clone was positive for expression of the V.~2 gene segment. These data confirm that the TCR V#2 gene segment is the most commonly used V~ gene segment by fetal liver 3'/8 T cells.
TCR 7 and r Chain Rearrangements in Fetal Liver T Cell
Clones. Sequence analysis of the TCR 8 chain from six fetal liver "y/8 T cell clones demonstrated that all but one had a V~2-D~3-Je3 rearrangement with limited junctional diversity (Fig. 5) . The V62-J~3 rearrangement of these clones was confirmed by genomic Southern blot analysis using probes for V~2 and J~3 (data not shown). Some clones showed strikingly similar protein sequences at the V~2-D~3-Je3 junction; clones L3 and L25 differed only by one residue at the V~2-D~3 junction, while clones L7 and L2G9 differed by two additional residues present at the Ds-J~ junction of clone L2G9. These results indicate that the majority of fetal liver 3~/8 T cell clones with CD4+CD8 -and CD4-CD8-phenotypes have V~2-De3-J~3 rearrangements with limited junctional diversity.
To determine rearrangements of the TCR "y locus among these T cell clones, cDNA samples were amplified using a C-r oligonudeotide in combination with primers specific for Vs2-Vs4 gene segments and for the Vsl family, which has five functional members. Of the six clones studied, two had a single Vsl-Cs rearrangement (clones L4B2, L2G9) while
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T Cell Receptor Rearrangements of Fetal Liver 3'/fi T Cells (anti-TCR V~l-J~l), Ti3,A (anti-TCK Vv9), and BB3 (anti-TCR Vs2). T cell clones L3, L7, L2G9, L4B2, L25, and L7F11 were positive for the TCR-~I mAb, while T cell clones I.,6, L38, L4G1, and L7F5
were positive for the WT31 mAb.
Three of the 3,/5 T cell clones (L3, L7, L2G9) expressed moderate levels of CD4, while three 3'/5 T cell clones (clones L4B2, L25, L7F11) were CD4-CD8-. Also, two ~x/3 T cell clones (L4G1, L7F5) had a CD4 + CD8 § phenotype. eDNA from fetal liver T cell clones was amplified using primers for V~2 and C6. Amplified products were cloned into M13 mpl9 and sequenced by the dideoxy method. Five of six clones were found to have a V,2-D63-JD rearrangement with little N region diversity, one clone had a V~3-D~3-J,2 rearrangement. radiated mice after injection of fetal liver precursors, even in the absence of a thymus. Also, nude mice were found to have substantial numbers of intestinal intraepithelial 3'/6 T cells despite the almost complete absence of c~/3 T cells. This demonstrates that at least a subset of 3"/6 T cells is thymus independent and that the fetal liver is at least one likely site of extrathymic maturation (12) . These results also suggest that the initial repertoire selection may take place in the fetal liver. Previous studies have demonstrated that thymic 3'/6 T cells can undergo both positive and negative selection (27) (28) (29) , and this selection may also take place in the fetal liver. During 3'/6 T cell development in mice, a sequential maturation of 3'/6 T cells with defined TCR 3' and ~ chain rearrangements can be observed (4, 30) . 3"//~ T cells with invariant receptors mature early and migrate to specific epithelial organs, while 3'/6 T cells with greater receptor diversity mature later and localize to the spleen (3) (4) (5) . Even though the maturation process of human 3"/6 T cells is not as well understood, there is evidence for a sequential appearance of 3'//~ T cells bearing specific receptors during thymic development. Vv1.8-Jvl.1/V~2-J~3 rearrangements are present in early fetal thymus, while Vs2-Jv2.3/V61-J61 represent the most common 3" and ~ chain rearrangements in postnatal thymus (6, 10) . Presumably due to extrathymic events, 3"/6 T cells with Vv2-Jsl.2/V~2-Jel rearrangements become the major 3//6 T cell population in blood during childhood (10, 11, 25) .
A comparison of TCR 6 chain sequences in human fetal thymus to the present results in human fetal liver demonstrates that similar TCR 6 chain rearrangements are found at both sites of T cell maturation. In both fetal liver and thymus, a predominant V~2-D~3-Je3 rearrangement with little N region diversity is seen (6, 7) . In contrast, 3' chain rearrangements of3"/6 T cells from fetal thymus (6) and fetal liver are different. During early thymic development, both Vsl and Vv2 are rearranged to the Jsl cluster (Vvl.8-Jsl.1 and Vs2-Jvl.3), while Vv2-Js2.3 rearrangements predominate during late stages of thymic development (6, 10) . In fetal liver, however, an ordered rearrangement process results in preferential rearrangement of Vsl segments to the Js2 cluster (specifically J-r2.3) and of V~2 and V~3 segments to the Jr1 cluster (J~1.2 and J~1.1, respectively). Fetal liver 3'/6 T cells may therefore have specificities different from 3'/6 T cells that mature in the thymus.
A subset of human fetal liver 3'/6 T cells ('~20%) has an unusual CD4 phenotype (13, 14) . Among the six fetal liver 3'//~ T cell clones established in this study, three were found to express moderate levels of CD4 and to use TCR 6 chains with a V~2-D~3-J~3 rearrangement. Such fetal liver 3'//~ T cells may have a specialized immune function as CD4 + CDS-3'/6 T cells from fetal liver do not possess an NKlike cytotoxic activity observed among CD4-CD8 + and CD4-CD8-3'//} T cells (13) . CD4+CD8 -3"/6 T cells from adult blood, which constitute a minor subpopulation of mature 3"/6 T ceils, were also found to be functionally different from CD4-CD8-and CD4-CD8 + 3'/6 T cells as they provide help for B cells but lack cytotoxic activity (15) . Thus, fetal liver 3'/6 T ceils, in particular the CD4 + CD8-subset, may have specific functions in the fetal immune system. The identification of ligands for fetal liver 3'/6 T ceUs would further our understanding of 3'/c3 T cells and their role in immune recognition during development.
